Publication:

American Journal of Obstetrics and Gynecology
Volume 218, Issue 6, June 2018, Pages 608.e1-608.e6

https://doi.org/10.1016/j.ajog.2018.03.012

Author(s):

Daniel L. Kuhr, Lindsey A. Sjaarda, Zeina Alkalaf, Ukpebo R. Omosigho, Matthew T. Connell, Robert M. Silver, Keewan Kim, Neil J. Perkins, Tiffany L. Holland, Tori C. Plowden, Enrique F. Schisterman, Sunni L. Mumford

Quansys Products Used:

Q-plex ELISA

Abstract:

Background
Prior studies have reported mixed results regarding relationships between vitamin D, androgens, and sex hormone–binding globulin in patients with polycystic ovary syndrome. However, less is known regarding these associations in eumenorrheic, premenopausal women.

Objective
Our objective was to study the relationships between serum vitamin D and androgen biomarkers in eumenorrheic women with a history of pregnancy loss who were attempting pregnancy.

Study Design
This was an analysis of a cohort of 1191 participants from the Effects of Aspirin in Gestation and Reproduction trial (2006–2012). Participants were attempting to conceive, aged 18–40 years, with 1–2 documented prior pregnancy losses and no history of infertility, and recruited from 4 academic medical centers in the United States. Serum vitamin D (25-hydroxyvitamin D) and hormone concentrations were measured at baseline.

Results
Vitamin D concentration was negatively associated with free androgen index (percentage change [95% confidence interval, –5% (–8% to –2%)] per 10 ng/mL increase) and positively associated with sex hormone–binding globulin (95% confidence interval, 4% [2–7%]), although not with total testosterone, free testosterone, or dehydroepiandrosterone sulfate after adjusting for age, body mass index, smoking status, race, income, education, physical activity, and season of blood draw.

Conclusion
Overall, vitamin D was associated with sex hormone–binding globulin and free androgen index in eumenorrheic women with prior pregnancy loss, suggesting that vitamin D may play a role in the bioavailability of androgens in eumenorrheic women. We are limited in making assessments regarding directionality, given the cross-sectional nature of our study.

As researchers and problem solvers ourselves, we understand the value of sound data. We are proud to be a part of research that can better the world. We value the relationships, partnerships, and friendships that we have built with the people who trust and use our technology. We are committed to building these relationships. You can count on us to answer the phone and take time to thoroughly address questions or concerns about any of our products. In an industry that is reputed for grandiose claims, we trust that our quality standards and our customer service set us apart from the competition. If you’re happy with our products or if you think we can do something better, we hope you will let us know.

1-888-782-6797

info@quansysbio.com

365 North 600 West Logan, UT 84321